- United States
- /
- Hospitality
- /
- NasdaqGS:EXPE
How Investors May Respond To Expedia Group (EXPE) Strong Q3 Results and Raised Revenue Outlook
Reviewed by Sasha Jovanovic
- On November 6, 2025, Expedia Group, Inc. reported third-quarter results showing sales of US$4.41 billion and net income of US$959 million, both higher than the same period last year, along with a declared quarterly dividend of 40 cents per share.
- The company's raised full-year revenue guidance and ongoing dividend payout reflect growing optimism about sustained travel demand and Expedia's continued cash generation.
- Let's explore how Expedia's improved third-quarter performance and higher annual outlook may influence its long-term growth narrative.
AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Expedia Group Investment Narrative Recap
To be a shareholder in Expedia Group, you need to believe in the durability of global travel demand and Expedia's ability to translate platform innovation into tangible financial growth, despite industry competition and platform recovery challenges. The latest earnings report, with improved sales and profitability, reinforces the biggest short-term catalyst: execution on new technology deployments. However, lingering softness in the US travel market and price sensitivity remain relevant risks, and the impact of the recent results on this risk appears only modest at present.
Among recent announcements, Expedia’s rollout of new AI-powered tools such as Smart Trip AI™ and enhanced B2B APIs stands out as most relevant. These product rollouts signal ongoing investment in the user experience and operational efficiency, directly tied to the company’s push to improve customer retention and marketing leverage, key ingredients in supporting revenue growth and margin expansion as highlighted in the latest quarter.
Yet, in contrast to these promising developments, investors should not overlook the persistent risk that...
Read the full narrative on Expedia Group (it's free!)
Expedia Group is expected to reach $16.9 billion in revenue and $2.1 billion in earnings by 2028. This outlook relies on an annual revenue growth rate of 6.4% and a $1.0 billion increase in earnings from the current $1.1 billion.
Uncover how Expedia Group's forecasts yield a $227.03 fair value, a 3% upside to its current price.
Exploring Other Perspectives
Eight members of the Simply Wall St Community estimated Expedia’s fair value between US$132.67 and US$437.22, reflecting widely differing future growth expectations. While many focus on new AI-driven travel tools as a revenue catalyst, shifts in US consumer demand could tell a different story for Expedia’s long-term profitability.
Explore 8 other fair value estimates on Expedia Group - why the stock might be worth as much as 99% more than the current price!
Build Your Own Expedia Group Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Expedia Group research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Expedia Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Expedia Group's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
- Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Expedia Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:EXPE
Expedia Group
Operates as an online travel company in the United States and internationally.
Proven track record with adequate balance sheet.
Similar Companies
Market Insights
Community Narratives

